SCHEMBL6311468

SCHEMBL6311468

Cc1c(-c2ccco2)c(Cl)c2c(nc3ccccn32)c1C#N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 11/20 0.45
ALDH1A1 P00352 10/20 0.45
MEN1 O00255 8/20 0.45
KMT2A Q03164 8/20 0.45
HSD17B10 Q99714 7/20 0.45
CASP1 P29466 2/20 0.45
BLM P54132 1/20 0.45
KDM4E B2RXH2 9/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 7/20 0.41
GAA P10253 6/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
LMNA P02545 1/20 0.38
TP53 P04637 2/20 0.38
PABPC1 P11940 1/20 0.38
RAB9A P51151 1/20 0.38
HTT P42858 2/20 0.38
NPSR1 Q6W5P4 2/20 0.37
TSHR P16473 1/20 0.37
ALOX15 P16050 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6310367 0.83 HTT (0.43) HPGDALDH1A1HSD17B10KDM4ESMN1; SMN2
SCHEMBL6319340 0.82 KDM4E (0.35) HPGDALDH1A1MEN1KMT2AHSD17B10
SCHEMBL6312786 0.81 KDM4E (0.44) HPGDALDH1A1MEN1KMT2AHSD17B10
SCHEMBL6319172 0.81 KDM4E (0.35) HPGDALDH1A1MEN1KMT2AHSD17B10
SCHEMBL6311042 0.79 KDM4E (0.45) HPGDALDH1A1MEN1KMT2AHSD17B10
SCHEMBL6309849 0.78 KDM4E (0.41) HPGDALDH1A1MEN1KMT2AHSD17B10
SCHEMBL6310683 0.78 KDM4E (0.36) HPGDALDH1A1MEN1KMT2AHSD17B10
SCHEMBL6312626 0.77 PIK3CD (0.45) HPGDALDH1A1KMT2AHSD17B10KDM4E
SCHEMBL6310328 0.77 NPSR1 (0.44) HPGDALDH1A1MEN1KMT2AHSD17B10
SCHEMBL6310653 0.77 KDM4E (0.40) HPGDALDH1A1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 HPGD 2061/4885ALDH1A1 2550/4885MEN1 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.